CAN Community Health

Fort Lauderdale, Florida 33316

0 studies enrolling now · 5 studies all time

What they study most

HIV-1-Infection, HIV-1-infection, Hiv Prevention, Pre-Exposure Prophylaxis (PrEP)

Studies at this site

• Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy — Running, not enrolling
• Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 — Running, not enrolling
• Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed — Running, not enrolling
• TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals — Completed
• PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP) — Status unconfirmed